Drug data last refreshed 7h ago · AI intelligence enriched 3w ago
OXYGEN, USP is a pharmaceutical-grade gaseous oxygen product administered via inhalation for respiratory support. It is indicated for patients requiring supplemental oxygen therapy across multiple clinical settings. The product functions as a basic medical gas essential for maintaining adequate tissue oxygenation in hypoxemic patients.
Product is at peak lifecycle stage with established market presence; commercial teams focus on maintaining market position against moderate competitive pressure (30%).
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
AI-Assisted Precision Hyperbaric Oxygen Therapy Based on Dynamic BIS-EEG Feedback for Patients With Disorders of Consciousness
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
MolecuLight All-in-One Oxygenation Clinical Utility
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Worked on OXYGEN, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on OXYGEN, USP offers stable career opportunities in a mature, essential-medicine market with focus on operational, regulatory, and distribution excellence. Career progression emphasizes supply chain optimization, healthcare provider relationships, and compliance rather than product innovation or clinical development.